<DOC>
	<DOCNO>NCT02878564</DOCNO>
	<brief_summary>The aim study assess impact Schistosoma mansoni infection treatment genital immunology HIV susceptibility Ugandan woman .</brief_summary>
	<brief_title>Effect Schistosomiasis Mansoni HIV Susceptibility Female Genital Immunology</brief_title>
	<detailed_description>Schistosomiasis mansoni water-borne disease cause helminth Schistosoma mansoni ( S. mansoni ) , adult worm deposit egg mesenteric blood vessel . Schistomiasis prevalence fishing community East Africa , particularly Lake Victoria region , exceed 60 % overlap region high prevalence HIV ( 29 % ) . A recent epidemiological study find association S. mansoni HIV infection adult woman reside near Lake Victoria Tanzania . Furthermore , primate study S. mansoni infection show increase susceptibility SIV infection rectal ( intravenous ) challenge , imply S. mansoni might increase HIV susceptibility alter local mucosal ( gut ) immunology . While S. mansoni directly infect genital tract , hypothesize inflammation cause gut may associate mucosal inflammation sit activation common mucosal home integrins a4b7 . Therefore study propose explore whether S. mansoni increase inflammation and/or HIV susceptibility endocervix adult woman . HIV-uninfected adult woman Entebbe , Uganda screen schistosomiasis use commercial CCA rapid test kit , infected woman fulfill study eligibility criterion recruit study . Kato-Katz microscopy analysis perform assess egg shed baseline . Additionally , urine microscopy do screen Schistosoma hematobium ( directly involve genital mucosa ) . Schistosomiasis treatment provide participant accord Ugandan clinical guideline . Endocervical cytobrush , vaginal SoftCup blood sample collect three time point ; baseline 4 8 week schistosomiasis treatment , stage menstrual cycle . Using ex vivo HIV entry assay mucosal cytokine microbiome analyse quantify effect S. mansoni treatment cervical HIV susceptibility genital inflammation .</detailed_description>
	<mesh_term>Disease Susceptibility</mesh_term>
	<mesh_term>Schistosomiasis</mesh_term>
	<mesh_term>Schistosomiasis mansoni</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>Positive ( score `` trace '' ) urine CCA rapid test Willing treat praziquantel Willing give inform consent , answer short questionnaire economic status , sexual risk behavior . Willing comply requirement protocol HIV classical STI ( see ) negative HIV infect Malaria infect Pregnant . Irregular menstrual cycle , actively menstruate time genital sampling . Tested positive classical STIs ( syphilis , gonorrhea , chlamydia , Trichomonas vaginalis ) genital ulcer Prior hysterectomy Deemed physician unlikely complete study protocol .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Schistosomiasis mansoni</keyword>
	<keyword>HIV susceptibility</keyword>
	<keyword>Genital immunology</keyword>
	<keyword>Mucosal immunology</keyword>
	<keyword>HIV entry assay</keyword>
	<keyword>Adult woman</keyword>
</DOC>